The Point Of Care Diagnostics market size is USD 15.3 Bn in 2026.
The Point Of Care Diagnostics market is projected to grow at a CAGR of 4% by 2033.
The Point Of Care Diagnostics market growth drivers include rising prevalence of infectious and chronic diseases, technological advancements in POCT, and increasing demand for rapid diagnostics.
North America is a dominating region for Point Of Care Diagnostics market.
Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Thermo Fisher Scientific, and Danaher Corporation are some leading industry players in the Point Of Care Diagnostics market.